- Home
- SIG vs LIVN Comparison
SIG vs LIVN Comparison
Compare SIG & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIG | LIVN |
|---|---|---|
| Founded | 1950 | 1987 |
| Country | Bermuda | United Kingdom |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 1997 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SIG | LIVN |
|---|---|---|
| Price | $94.57 | $75.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $111.14 | $72.43 |
| AVG Volume (30 Days) | 558.0K | ★ 628.8K |
| Earning Date | 06-02-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | ★ 974.07 | N/A |
| EPS | 0.78 | ★ 2.33 |
| Revenue | ★ $6,247,100,000.00 | N/A |
| Revenue This Year | $1.39 | $9.79 |
| Revenue Next Year | $1.71 | $6.63 |
| P/E Ratio | ★ $123.76 | $195.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $71.62 | $48.57 |
| 52 Week High | $110.20 | $85.76 |
Technical Indicators
Market Signals| Indicator | SIG | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding, and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Outlet. Geographically, it operates in the USA, Canada, the UK, and Ireland, with the maximum revenue from the USA.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.